Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

1.

Gastrointestinal stromal tumor of the lesser omentum: a case report and review of the literature.

Ninomiya S, Hiroishi K, Shiromizu A, Ueda Y, Shiraishi N, Inomata M, Arita T.

J Surg Case Rep. 2019 Feb 12;2019(2):rjz035. doi: 10.1093/jscr/rjz035. eCollection 2019 Feb.

2.

Assessment of colonic contents in patients with chronic constipation using MRI.

Inoh Y, Kanoshima K, Ohkuma K, Fuyuki A, Uchiyama S, Ohkubo H, Higurashi T, Iida H, Nonaka T, Fujita K, Kusakabe A, Inamori M, Hiroishi K, Nagase H, Nakajima A, Takahara T.

J Clin Biochem Nutr. 2018 May;62(3):277-280. doi: 10.3164/jcbn.17-104. Epub 2018 Mar 17.

3.

Increased expression of immuno-inhibitory molecules on peripheral blood lymphocytes may suppress disease progression in autoimmune hepatitis.

Hiraide-Sasagawa A, Hiroishi K, Shimazaki T, Eguchi J, Ishii S, Morikawa K, Sakaki M, Doi H, Omori R, Kajiwara A, Hayashi E, Shiina M, Hirayama Y, Imawari M.

Hepatol Res. 2015 Nov;45(11):1152-4. doi: 10.1111/hepr.12479. No abstract available.

PMID:
25581267
4.

Contribution of diuretic therapy with human serum albumin to the management of ascites in patients with advanced liver cirrhosis: A prospective cohort study.

Nakamura T, Sata M, Hiroishi K, Masaki N, Moriwaki H, Murawaki Y, Yatsuhashi H, Fujiyama S, Imawari M.

Mol Clin Oncol. 2014 May;2(3):349-355. Epub 2014 Jan 16.

5.

In vivo immunological antitumor effect of OK-432-stimulated dendritic cell transfer after radiofrequency ablation.

Nakagawa H, Mizukoshi E, Iida N, Terashima T, Kitahara M, Marukawa Y, Kitamura K, Nakamoto Y, Hiroishi K, Imawari M, Kaneko S.

Cancer Immunol Immunother. 2014 Apr;63(4):347-56. doi: 10.1007/s00262-013-1514-7. Epub 2014 Jan 3.

PMID:
24384836
6.

Hepatitis C patients on maintenance hemodialysis show complex immune disturbances in the peripheral blood.

Shiina M, Kobayashi K, Hiroishi K, Imawari M.

Viral Immunol. 2013 Oct;26(5):351-6. doi: 10.1089/vim.2013.0026. Epub 2013 Sep 10.

PMID:
24020832
7.

Genetic polymorphism in cyclooxygenase-2 promoter affects hepatic inflammation and fibrosis in patients with chronic hepatitis C.

Miyashita M, Ito T, Sakaki M, Kajiwara A, Nozawa H, Hiroishi K, Kobayashi M, Kumada H, Imawari M.

J Viral Hepat. 2012 Sep;19(9):608-14. doi: 10.1111/j.1365-2893.2011.01580.x. Epub 2012 Jan 28.

PMID:
22863264
8.

Effects of interferon-α-transduced tumor cell vaccines and blockade of programmed cell death-1 on the growth of established tumors.

Omori R, Eguchi J, Hiroishi K, Ishii S, Hiraide A, Sakaki M, Doi H, Kajiwara A, Ito T, Kogo M, Imawari M.

Cancer Gene Ther. 2012 Sep;19(9):637-43. doi: 10.1038/cgt.2012.42. Epub 2012 Jul 13.

PMID:
22790963
9.

Transrectal peritoneal access with the submucosal tunnel technique in NOTES: a porcine survival study.

Kono Y, Yasuda K, Hiroishi K, Akagi T, Kawaguchi K, Suzuki K, Yoshizumi F, Inomata M, Shiraishi N, Kitano S.

Surg Endosc. 2013 Jan;27(1):278-85. doi: 10.1007/s00464-012-2441-y. Epub 2012 Jun 30.

PMID:
22752285
10.

Guideline on the use of new anticancer drugs for the treatment of Hepatocellular Carcinoma 2010 update.

Kaneko S, Furuse J, Kudo M, Ikeda K, Honda M, Nakamoto Y, Onchi M, Shiota G, Yokosuka O, Sakaida I, Takehara T, Ueno Y, Hiroishi K, Nishiguchi S, Moriwaki H, Yamamoto K, Sata M, Obi S, Miyayama S, Imai Y.

Hepatol Res. 2012 Jun;42(6):523-42. doi: 10.1111/j.1872-034X.2012.00981.x.

PMID:
22568457
11.

Interleukin-4 and CpG oligonucleotide therapy suppresses the outgrowth of tumors by activating tumor-specific Th1-type immune responses.

Kajiwara A, Doi H, Eguchi J, Ishii S, Hiraide-Sasagawa A, Sakaki M, Omori R, Hiroishi K, Imawari M.

Oncol Rep. 2012 Jun;27(6):1765-71. doi: 10.3892/or.2012.1723. Epub 2012 Mar 15.

PMID:
22426807
12.

Lymphotropic hepatitis C virus has an interferon-resistant phenotype.

Inokuchi M, Ito T, Nozawa H, Miyashita M, Morikawa K, Uchikoshi M, Shimozuma Y, Arai J, Shimazaki T, Hiroishi K, Imawari M.

J Viral Hepat. 2012 Apr;19(4):254-62. doi: 10.1111/j.1365-2893.2011.01541.x. Epub 2011 Oct 17.

PMID:
22404723
13.

[Mechanism of HCV persistence].

Hiroishi K, Ishii S, Imawari M.

Nihon Rinsho. 2011 May;69 Suppl 4:92-6. Japanese. No abstract available.

PMID:
22096900
14.

Cancer stem cell-related factors are associated with the efficacy of pre-operative chemoradiotherapy for locally advanced rectal cancer.

Hiroishi K, Inomata M, Kashima K, Yasuda K, Shiraishi N, Yokoyama S, Kitano S.

Exp Ther Med. 2011 May;2(3):465-470. Epub 2011 Mar 21.

15.

Reactivation of Epstein-Barr virus in B cells of patients with chronic hepatitis C.

Shimozuma Y, Ito T, Inokuchi M, Uchikoshi M, Miyashita M, Nozawa H, Shimazaki T, Hiroishi K, Imawari M.

J Med Virol. 2010 Dec;82(12):2064-72. doi: 10.1002/jmv.21890.

PMID:
20981794
16.

Cyclooxygenase-2 gene promoter polymorphisms affect susceptibility to hepatitis C virus infection and disease progression.

Sakaki M, Makino R, Hiroishi K, Ueda K, Eguchi J, Hiraide A, Doi H, Omori R, Imawari M.

Hepatol Res. 2010 Dec;40(12):1219-26. doi: 10.1111/j.1872-034X.2010.00727.x. Epub 2010 Sep 28.

PMID:
20880066
17.

[A case of scirrhous gastric carcinoma with peritoneal dissemination which was treated by curative gastrectomy after S-1/CDDP chemotherapy].

Akagi T, Etoh T, Eguchi H, Hiroishi K, Ueda Y, Yasuda K, Noguchi T, Shiraishi N, Kitano S.

Gan To Kagaku Ryoho. 2010 Aug;37(8):1573-7. Review. Japanese.

PMID:
20716890
18.

Case series of intra-abdominal adhesions induced by artificial ulceration after endoscopic submucosal dissection before additional laparoscopic gastrectomy.

Akagi T, Shiraishi N, Hiroishi K, Etoh T, Yasuda K, Kitano S.

Gastrointest Endosc. 2010 Aug;72(2):438-43. doi: 10.1016/j.gie.2010.03.1066. Epub 2010 Jun 11.

PMID:
20541190
19.

Immune response of cytotoxic T lymphocytes and possibility of vaccine development for hepatitis C virus infection.

Hiroishi K, Eguchi J, Ishii S, Hiraide A, Sakaki M, Doi H, Omori R, Imawari M.

J Biomed Biotechnol. 2010;2010:263810. doi: 10.1155/2010/263810. Epub 2010 May 20.

20.

Strong CD8(+) T-cell responses against tumor-associated antigens prolong the recurrence-free interval after tumor treatment in patients with hepatocellular carcinoma.

Hiroishi K, Eguchi J, Baba T, Shimazaki T, Ishii S, Hiraide A, Sakaki M, Doi H, Uozumi S, Omori R, Matsumura T, Yanagawa T, Ito T, Imawari M.

J Gastroenterol. 2010 Apr;45(4):451-8. doi: 10.1007/s00535-009-0155-2. Epub 2009 Nov 20.

PMID:
19936602
21.

Two cases of tuberculous peritonitis with liver cirrhosis complicated by refractory ascites.

Shimozuma Y, Ito T, Ishii S, Inokuchi M, Uchikoshi M, Oyama M, Hiroishi K, Imawari M.

Clin J Gastroenterol. 2009 Aug;2(4):300-305. doi: 10.1007/s12328-009-0083-y. Epub 2009 May 13.

PMID:
26192430
22.

Infection of B cells with hepatitis C virus for the development of lymphoproliferative disorders in patients with chronic hepatitis C.

Inokuchi M, Ito T, Uchikoshi M, Shimozuma Y, Morikawa K, Nozawa H, Shimazaki T, Hiroishi K, Miyakawa Y, Imawari M.

J Med Virol. 2009 Apr;81(4):619-27. doi: 10.1002/jmv.21388.

PMID:
19235854
23.

Magnitude of CD8 T-cell responses against hepatitis C virus and severity of hepatitis do not necessarily determine outcomes in acute hepatitis C virus infection.

Doi H, Hiroishi K, Shimazaki T, Eguchi J, Baba T, Ito T, Matsumura T, Nozawa H, Morikawa K, Ishii S, Hiraide A, Sakaki M, Imawari M.

Hepatol Res. 2009 Mar;39(3):256-65. doi: 10.1111/j.1872-034X.2008.00459.x. Epub 2008 Nov 5.

PMID:
19054151
24.

Immune responses in hepatitis C virus infection and mechanisms of hepatitis C virus persistence.

Hiroishi K, Ito T, Imawari M.

J Gastroenterol Hepatol. 2008 Oct;23(10):1473-82. doi: 10.1111/j.1440-1746.2008.05475.x. Epub 2008 Aug 28. Review.

PMID:
18761560
25.

Dendritic cells stimulated with cytidine-phosphate-guanosine oligodeoxynucleotides and interferon-alpha-expressing tumor cells effectively reduce outgrowth of established tumors in vivo.

Hiraide A, Hiroishi K, Eguchi J, Ishii S, Doi H, Imawari M.

Cancer Sci. 2008 Aug;99(8):1663-9. doi: 10.1111/j.1349-7006.2008.00858.x.

26.

Intrahepatic status of regulatory T cells in autoimmune liver diseases and chronic viral hepatitis.

Sakaki M, Hiroishi K, Baba T, Ito T, Hirayama Y, Saito K, Tonoike T, Kushima M, Imawari M.

Hepatol Res. 2008 Apr;38(4):354-61. Epub 2007 Nov 15.

PMID:
18021223
27.

[Progressing primary AL-type amyloidosis benefited by dexamethasone].

Uchikoshi M, Ito T, Hirayama Y, Kaneko K, Ikegami A, Katagiri A, Watanabe H, Hiroishi K, Imawari M.

Nihon Naika Gakkai Zasshi. 2007 Jun 10;96(6):1202-4. Japanese. No abstract available.

PMID:
17607997
28.

Immune responses of liver-infiltrating lymphocytes and peripheral blood mononuclear cells to hepatitis C virus core and NS3 antigens.

Tajimi M, Ugajin T, Ota M, Hiroishi K, Nakamura I, Imawari M.

Hepatol Res. 2006 Aug;35(4):250-5. Epub 2006 Jun 12.

PMID:
16765635
29.
30.
31.

Interleukin-4 gene transduced tumor cells promote a potent tumor-specific Th1-type response in cooperation with interferon-alpha transduction.

Eguchi J, Hiroishi K, Ishii S, Baba T, Matsumura T, Hiraide A, Okada H, Imawari M.

Gene Ther. 2005 May;12(9):733-41.

PMID:
15772692
32.

[Role of CTL in liver injury of patients with HCV infection].

Hiroishi K, Matsumura T, Imawari M.

Nihon Rinsho. 2004 Jul;62 Suppl 7(Pt 1):159-63. Review. Japanese. No abstract available.

PMID:
15359785
33.

Dendritic cell maturation induced by delivery of ultraviolet-mediated apoptotic colorectal cancer cell lines.

Ishii S, Hiroishi K, Eguchi J, Mitamura K.

Anticancer Res. 2003 May-Jun;23(3B):2457-63.

PMID:
12894528
34.

Interferon-alpha and interleukin-12 gene therapy of cancer: interferon-alpha induces tumor-specific immune responses while interleukin-12 stimulates non-specific killing.

Eguchi J, Hiroishi K, Ishii S, Mitamura K.

Cancer Immunol Immunother. 2003 Jun;52(6):378-86. Epub 2003 Mar 18.

PMID:
12739068
35.

Differential effect of cytotoxic T lymphocyte variant epitopes on generation and cytotoxicity in chronic hepatitis C virus infection.

Hiroishi K, Eguchi J, Ishii S, Okamoto H, Mitamura K, Imawari M.

Hepatol Res. 2002 Oct;24(2):91.

PMID:
12270736
36.

Murine dendritic cell-induced tumor apoptosis is partially mediated by nitric oxide.

Shimamura H, Cumberland R, Hiroishi K, Watkins SC, Lotze MT, Baar J.

J Immunother. 2002 May-Jun;25(3):226-34.

PMID:
12000864
37.

[Successful treatment for disseminated intra-vascular coagulation due to sepsis and brain abscess with low molecular weight heparin in a patient with antiphospholipid syndrome].

Hiroishi K, Shigenobu Y, Asai M, Tsuzuki Y, Hayashi N, Tominaga K, Matsui K, Hada T, Higashino K.

Nihon Rinsho Meneki Gakkai Kaishi. 1999 Feb;22(1):37-42. Japanese.

PMID:
11185690
38.

CC chemokine receptor-7 on dendritic cells is induced after interaction with apoptotic tumor cells: critical role in migration from the tumor site to draining lymph nodes.

Hirao M, Onai N, Hiroishi K, Watkins SC, Matsushima K, Robbins PD, Lotze MT, Tahara H.

Cancer Res. 2000 Apr 15;60(8):2209-17.

40.

IFN-alpha-expressing tumor cells enhance generation and promote survival of tumor-specific CTLs.

Hiroishi K, Tüting T, Lotze MT.

J Immunol. 2000 Jan 15;164(2):567-72.

41.

High serum level of macrophage-colony stimulating factor (M-CSF) in adult-onset Still's disease.

Matsui K, Tsuchida T, Hiroishi K, Tominaga K, Hayashi N, Hada T, Higashino K.

Rheumatology (Oxford). 1999 May;38(5):477-8. No abstract available.

PMID:
10371293
42.

IL-18 up-regulates perforin-mediated NK activity without increasing perforin messenger RNA expression by binding to constitutively expressed IL-18 receptor.

Hyodo Y, Matsui K, Hayashi N, Tsutsui H, Kashiwamura S, Yamauchi H, Hiroishi K, Takeda K, Tagawa Y, Iwakura Y, Kayagaki N, Kurimoto M, Okamura H, Hada T, Yagita H, Akira S, Nakanishi K, Higashino K.

J Immunol. 1999 Feb 1;162(3):1662-8.

43.

Effect of bucladesine sodium on the plasma concentrations and urinary excretion of purine bases and uridine.

Yamamoto T, Moriwaki Y, Takahashi S, Tsutsumi Z, Ohata H, Fujita T, Yamakita J, Nakano T, Hiroishi K, Higashino K.

Metabolism. 1998 Aug;47(8):1005-8.

PMID:
9712000
44.

Xylitol-induced increase in the plasma concentration and urinary excretion of uridine and purine bases.

Yamamoto T, Moriwaki Y, Takahashi S, Tsutsumi Z, Yamakita J, Nakano T, Hiroishi K, Higashino K.

Metabolism. 1998 Jun;47(6):739-43.

PMID:
9627375
45.

Effect of glucagon on the plasma concentration of uridine.

Yamamoto T, Moriwaki Y, Takahashi S, Tsutsumi Z, Ohata H, Yamakita J, Nakano T, Hiroishi K, Higashino K.

Metabolism. 1998 Jun;47(6):695-8.

PMID:
9627369
46.

Impaired induction of cytotoxic T lymphocytes by antagonism of a weak agonist borne by a variant hepatitis C virus epitope.

Kaneko T, Moriyama T, Udaka K, Hiroishi K, Kita H, Okamoto H, Yagita H, Okumura K, Imawari M.

Eur J Immunol. 1997 Jul;27(7):1782-7.

PMID:
9247592
47.

Propionibacterium acnes treatment diminishes CD4+ NK1.1+ T cells but induces type I T cells in the liver by induction of IL-12 and IL-18 production from Kupffer cells.

Matsui K, Yoshimoto T, Tsutsui H, Hyodo Y, Hayashi N, Hiroishi K, Kawada N, Okamura H, Nakanishi K, Higashino K.

J Immunol. 1997 Jul 1;159(1):97-106.

PMID:
9200444
48.

Perforin, Fas/Fas ligand, and TNF-alpha pathways as specific and bystander killing mechanisms of hepatitis C virus-specific human CTL.

Ando K, Hiroishi K, Kaneko T, Moriyama T, Muto Y, Kayagaki N, Yagita H, Okumura K, Imawari M.

J Immunol. 1997 Jun 1;158(11):5283-91.

PMID:
9164947
49.

Effect of ethanol and fructose on plasma uridine and purine bases.

Yamamoto T, Moriwaki Y, Takahashi S, Yamakita J, Tsutsumi Z, Ohata H, Hiroishi K, Nakano T, Higashino K.

Metabolism. 1997 May;46(5):544-7.

PMID:
9160822
50.

Effect of glucagon on renal excretion of oxypurinol and purine bases.

Yamamoto T, Moriwaki Y, Takahashi S, Tsutsumi Z, Hiroishi K, Yamakita J, Nakano T, Higashino K.

J Rheumatol. 1997 Apr;24(4):708-13.

PMID:
9101506

Supplemental Content

Loading ...
Support Center